# Immunitas — WebsDocs ASG Directory Profile

This is a public business listing published by the WebsDocs ASG Directory.
It provides machine-readable public information and static answers. It is not a live seller AI.



Canonical Directory profile:
https://directory.websdocs.com/business/immunitas

Canonical Directory JSON:
https://directory.websdocs.com/business/immunitas.json

Machine-readable public profile:
https://aig.websdocs.com/ai/immunitas/profile

Company profile JSON:
https://aig.websdocs.com/ai/immunitas/data/aig-company-profile.json

Static Agent Card:
https://aig.websdocs.com/ai/immunitas/.well-known/agent-card.json

Public discovery endpoints:
- Profile: https://aig.websdocs.com/ai/immunitas/profile
- Company JSON: https://aig.websdocs.com/ai/immunitas/data/aig-company-profile.json
- Services: https://aig.websdocs.com/ai/immunitas/services
- Offers: https://aig.websdocs.com/ai/immunitas/offers
- Schema: https://aig.websdocs.com/ai/immunitas/schema.jsonld
- Agent Card: https://aig.websdocs.com/ai/immunitas/.well-known/agent-card.json

Business summary:
Immunitas 0 Skip to Content Our Biology News Contact Open Menu Close Menu Our Biology News Contact Open Menu Close Menu Our Biology News Contact NOVEL BIOLOGY PATIENT IMPACT Immunitas was founded to discover and develop novel, differentiated therapeutics for patients with cancer and autoimmune diseases. Our lead program, IMT-009, targets CD161 for treatment of solid tumors and hematological malignancies. Our second program, recently licensed to Boehringer Ingelheim, is a novel therapeutic for the treatment of autoimmune disease.

Status and boundaries:
- Directory public profile
- Customer-owned domain required: not applicable
- Active seller agent: false
- A2A messaging: unavailable
- Live reasoning or RAG: unavailable
- UCP and MCP: unavailable
- Checkout and payment execution: unavailable
- Private data access: unavailable

Use the canonical Directory profile for current public evidence.  Do not infer that a live AI Sales Gateway is active.